Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.

Authors

Jeffrey M Ashburner
Alan S Go
Yuchiao Chang
Margaret C Fang
Lisa Fredman
Katie M Applebaum, George Washington UniversityFollow
Daniel E Singer

Document Type

Journal Article

Publication Date

1-1-2017

Journal

Journal of the American Geriatrics Society

Volume

65

Issue

1

DOI

10.1111/jgs.14516

Keywords

Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; California; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Regression Analysis; Risk Factors; Stroke; Thromboembolism; Warfarin

APA Citation

Ashburner, J., Go, A., Chang, Y., Fang, M., Fredman, L., Applebaum, K., & Singer, D. (2017). Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.. Journal of the American Geriatrics Society, 65 (1). http://dx.doi.org/10.1111/jgs.14516

Peer Reviewed

1